NCT03696628View on ClinicalTrials.gov

Modeling and Pharmacological Targeting of Genetic Cardiomyopathy in Children Via Cardiomyocytes Derived From Induced Pluripotent Stem Cells (DMDstem)

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 25, 2017

Primary Completion Date

January 20, 2021

Study Completion Date

January 20, 2021

Conditions
Cardiomyopathy, Familial
Interventions
OTHER

Electrocardiogram

heart testing

OTHER

physical examination

done by the investigator

OTHER

echocardiography

heart testing

BIOLOGICAL

blood test

A sample of blood will be taken to each patient or healthy children in order to generate hiPSC-cardiomyocytes

Trial Locations (1)

34090

CHU Arnaud de Villeneuve, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT03696628 - Modeling and Pharmacological Targeting of Genetic Cardiomyopathy in Children Via Cardiomyocytes Derived From Induced Pluripotent Stem Cells (DMDstem) | Biotech Hunter | Biotech Hunter